US sharemarkets ended mixed on Tuesday. Oil prices rose, boosting the energy sector. But the healthcare sector eased. Shares in Biogen and Alexion fell after both reported failures of their drugs in clinical trials.
Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X
Recent Posts
- Harnessing the Power of Energy: A Multifaceted ExplorationDecember 23, 2024
- French Budget Plan Welcomed by InvestorsDecember 23, 2024
- Navigating the Complex Landscape of Modern PoliticsDecember 23, 2024
- RBA Holds Steady on Interest Rates, Awaiting Inflation...December 23, 2024
- The Unexpected Joy of Imperfection: Embracing Our Flaws...December 23, 2024
All Categories
- Battery Technology (2)
- Biotechnology (101)
- brekkie wrap (6)
- Broker News (2466)
- Commodities (1680)
- Hydrogen (6)
- Lithium (106)
- Potash (11)
- Rare Earths (6)
- Renewables (35)
- Company (6)
- Corporate Connect Research (24)
- Currencies (42)
- Cryptocurrencies (28)
- daily special (5)
- David Bassanese (90)
- Economics (3085)
- ESG (117)
- Etfs (500)
- EV Space (128)
- FinTech (26)
- Fixed Interest (231)
- FNN Content (6122)
- Franklin Templeton (1)
- Funds (1422)
- Gavin Wendt (141)
- Greg Tolpigin (75)
- hot stocks (10)
- Infrastructure (28)
- Interest Rates (386)
- investor blend (9)
- IPOs (20)
- James Dunn (185)
- Kris Walesby (67)
- LICs (162)
- Marc Sinatra (4)
- market mocha (9)
- Market Reports Text (283)
- Markets (14003)
- Media (71)
- Noosa Mining Conference (29)
- Podcasts (1)
- Politics (53)
- Product Profiles (23)
- Property (225)
- Reports (511)
- Retail (254)
- Shane Oliver (260)
- Shares (18221)
- Stocks of the Hour (300)
- sip & learn (1)
- sip and learn (5)
- Sponsored Content (32)
- Strategy (204)
- Super (36)
- Technical Analysis (5)
- Technology (419)
- The Week that Was (112)
- Tim Boreham (85)
- Uncategorized (157)
- Video (4333)
- Webinars (194)
- Weekly Wrap (821)